TOXBAR Trademark

Trademark Overview


On Tuesday, September 2, 2025, a trademark application was filed for TOXBAR with the United States Patent and Trademark Office. The USPTO has given the TOXBAR trademark a serial number of 99369694. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, July 16, 2026. This trademark is owned by Athena Medtec Limited. The TOXBAR trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical preparations in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical preparations in the nature of a gel substance injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Medical preparations in the nature of a gel barrier product used to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.

Medical devices, namely, surgical implants made of synthetic materials in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical devices, namely, surgical implants made of synthetic materials in the nature of a gel injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Kits for use in medical and surgical procedures comprising applicators in the nature of injection needles and a hyaluronic acid based substance for medical use; surgical and medical apparatus and instruments for use in injecting a gel between an organ at risk and an organ with cancer creating a space between the two for protecting the organ at risk from radiation during radiotherapy treatment for the organ with cancer; Medical apparatus in the nature of a medical barrier device used to c...
toxbar

General Information


Serial Number99369694
Word MarkTOXBAR
Filing DateTuesday, September 2, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, July 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical preparations in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical preparations in the nature of a gel substance injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Medical preparations in the nature of a gel barrier product used to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.
Goods and ServicesMedical devices, namely, surgical implants made of synthetic materials in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical devices, namely, surgical implants made of synthetic materials in the nature of a gel injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Kits for use in medical and surgical procedures comprising applicators in the nature of injection needles and a hyaluronic acid based substance for medical use; surgical and medical apparatus and instruments for use in injecting a gel between an organ at risk and an organ with cancer creating a space between the two for protecting the organ at risk from radiation during radiotherapy treatment for the organ with cancer; Medical apparatus in the nature of a medical barrier device used to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAthena Medtec Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSurrey KT6 6QL
GB

Trademark Events


Event DateEvent Description
Tuesday, September 2, 2025NEW APPLICATION ENTERED
Tuesday, September 2, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, January 21, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 22, 2026ASSIGNED TO EXAMINER
Thursday, January 22, 2026NON-FINAL ACTION WRITTEN
Thursday, January 22, 2026NON-FINAL ACTION E-MAILED
Thursday, January 22, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 8, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, April 8, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, July 15, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 15, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 16, 2026SUSPENSION LETTER WRITTEN
Thursday, July 16, 2026LETTER OF SUSPENSION E-MAILED
Thursday, July 16, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED